Enzymotec has announced that clinical trials for its lipid-based ingredient line for infant nutrition yielded positive results.

Neptune and Acasti, a Neptune subsidiary, have announced that they have been unable to conclude a final settlement agreement through mediation with En

Neptune has announced that the United States Patent and Trademark Office (“USPTO” recently issued a Right of Appeal Notice in an inter partes re-exam

China is setting the regional benchmark for innovation in premium infant foods, according to Enzymotec, the Israel-based lipids-maker.

Biotech company Enzymotec has reported that clinical trials for its lipid-based ingredient line for infant nutrition yielded positive results.

A randomised, double-blind, controlled clinical trial on bone strength in term infants fed a high beta-palmitate formula was recently published in the